▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

IFF To Present At Barclays 2021 Global Consumer Staples Conference; Webcast At 12:00 PM ET

By RTTNews Staff Writer ✉ | Published: 9/9/2021 11:00 AM ET

International Flavors And Fragrances Inc (IFF) will participate in a virtual fireside chat at the Barclays 2021 Global Consumer Staples Conference.

The event is scheduled to begin at 12:00 PM ET on September 9, 2021.

To access the live webcast, log on to http://ir.iff.com

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In October 2021 PDUFA FDA Pompe Disease

Biotech Stocks Facing FDA Decision In October 2021

Biotech Stocks Facing FDA Decision In September 2021 PDUFA FDA Atopic dermatitis Parkinsons

Biotech Stocks Facing FDA Decision In September 2021

Biotech Stocks Facing FDA Decision In August 2021 FDA PDUFA acne CKD encephalitis

Biotech Stocks Facing FDA Decision In August 2021

Latest Updates on COVID-19

Vaccination Requirements Driving Up Vaccination Rates: White House

U.S. Covid Cases At Lowest Level In 3 Months

Will FDA Allow 'mix And Match' Of Covid Booster Shots?

U.S. Covid Metrics Steadily Declining

White House Vows To Implement Vaccination Mandate, Including In States Opposing It

Read More

COVID-19: Drugs in Development

RELATED NEWS

IFF To Present At Barclays 2021 Global Consumer Staples Conference; Webcast At 12:00 PM ET

IFF To Sell Microbial Control Business Unit To Lanxess For About $1.3 Bln

International Flavors And Fragrances Q2 21 Earnings Conference Call At 10:00 AM ET

International Flavors And Fragrances Inc Q2 adjusted earnings Beat Estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

Merck Recalls About 22K Vials Of Antibiotic Injection Cubicin

NRA Suggests Expanded Outdoor Dining As Winter Approaches

FDA To Probe Salmonella Outbreak Linked To Whole, Fresh Onions

American Airlines Q3 Results Better Than Estimates

Demaiz Recalls Beef And Pork Tamale Products

McDonald's Says Equal Pay For Women Is Only A Beginning

Verizon Q3 Profit Tops Estimates; Raises 2021 Guidance

Abbott Laboratories Boosts FY21 Outlook - Quick Facts

Nestle Lifts FY21 Organic Sales Growth View After Higher 9M Sales; Stock Up

Kettle Classic Clam Chowder With Uncured Bacon Sold At Costco Recalled

FDA OKs Cyltezo As First Interchangeable Biosimilar To Humira

Will FDA Allow 'mix And Match' Of Covid Booster Shots?

Valneva Reports Positive Topline Results From Phase 3 Trial Of COVID-19 Vaccine Candidate

UCB : FDA Defers Action On BLA For Bimekizumab Due To Travel Restrictions

FDA Approves Roche's Tecentriq As Adjuvant Treatment For Early Non-small Cell Lung Cancer

LumiraDx Gets Emergency Use Approval In India For COVID-19 Antigen Test; Stock Surges

TeamViewer Extends CEO Oliver Steil's Contract Until Oct. 2024; CFO To Quit Next Year

Mueller Industries Reports Gain In Q3 Earnings

FDA OKs Cyltezo As First Interchangeable Biosimilar To Humira

Johnson & Johnson Q3 Earnings Top Estimates; Lifts FY21 View Above Market

Bryant Ranch Recalls Methocarbamol 500mg Bottles

Lark Distilling To Acquire Kernke Family Shene Estate In $40 Mln Cash, Share Deal

Roche Q3 Group Sales Rise; Lifts FY21 Outlook - Quick Facts

Will FDA Allow 'mix And Match' Of Covid Booster Shots?

Harmony Biosciences - Beyond Wakix And Narcolepsy

Commerce Bancshares Inc. Q3 Income Drops

McBride Still Sees FY22 Earnings To Be Weighted To H2 Of The Financial Year

Bellway Plc FY Underlying Profit Rises; Revenue Up 40.3% - Quick Facts

BHP Q1 Iron Ore Production Down

Lawmakers Send Strong Message To Amazon CEO

Southwest Airlines Unveils 10-Year Environmental Sustainability Plan

Zions Bancorp Earnings Rise In Q3, Beats estimates

Apple Unveils Third-Gen AirPods

Facebook To Create 10,000 Jobs In EU To Build 'metaverse'

Noront Board Determines Wyloo Metals' Proposal As Superior Proposal To BHP Offer

Adamis Pharma Reports FDA Approval Of ZIMHI In Treatment Of Opioid Overdose - Quick Facts